Evidence map›Paper›PMID 31091687›Full record

ArticleTropical medicine and infectious disease2019

Achieving Health Security and Threat Reduction through Sharing Sequence Data.

Kenneth Yeh, Jeanne Fair, Helen Cui, Carl Newman, Gavin Braunstein, Gvantsa Chanturia, Sapana Vora, Kendra Chittenden, Ashley Tseng, Corina Monagin and 1 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kenneth YehMRIGlobal, Gaithersburg, MD 20878, USA. kyeh@mriglobal.org.ORCID 0000-0003-3996-6446
Jeanne FairLos Alamos National Laboratory, Los Alamos, NM 87545, USA. jmfair@lanl.gov.ORCID 0000-0002-3377-6134
Helen CuiLos Alamos National Laboratory, Los Alamos, NM 87545, USA. hhcui@lanl.gov.
Carl NewmanDefense Threat Reduction Agency, Fort Belvoir, VA 22060, USA. carl.i.newman.civ@mail.mil.
Gavin BraunsteinDefense Threat Reduction Agency, Fort Belvoir, VA 22060, USA. gavin.m.braunstein.civ@mail.mil.
Gvantsa ChanturiaNational Center for Disease Control and Public Health, Tbilisi 0198, Georgia. gvantsa.chanturia@ncdc.ge.
Sapana VoraDepartment of State, Washington, DC 20520, USA. VoraSR@state.gov.
Kendra ChittendenUSAID, Bureau of Global Health, Arlington, VA 22202, USA. kchittenden@usaid.gov.
Ashley TsengDepartment of Epidemiology, Columbia University, Mailman School of Public Health, New York, NY 10032, USA. at3346@cumc.columbia.edu.
Corina MonaginOne Health Institute, University of California, Davis, CA 95616, USA. cmonagin@gmail.com.
Jacqueline FletcherNational Institute for Microbial Forensics & Food and Agricultural Biosecurity, Oklahoma State University, Stillwater, OK 74078, USA. jacqueline.fletcher@okstate.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid development and broad applications of next-generation sequencing platforms and bioinformatic analytical tools, genomics has become a popular area for biosurveillance and international scientific collaboration. Governments from countries including the United States (US), Canada, Germany, and the United Kingdom have leveraged these advancements to support international cooperative programs that aim to reduce biological threats and build scientific capacity worldwide. A recent conference panel addressed the impacts of the enhancement of genomic sequencing capabilities through three major US bioengagement programs on international scientific engagement and biosecurity risk reduction. The panel contrasted the risks and benefits of supporting the enhancement of genomic sequencing capabilities through international scientific engagement to achieve biological threat reduction and global health security. The lower costs and new bioinformatic tools available have led to the greater application of sequencing to biosurveillance. Strengthening sequencing capabilities globally for the diagnosis and detection of infectious diseases through mutual collaborations has a high return on investment for increasing global health security. International collaborations based on genomics and shared sequence data can build and leverage scientific networks and improve the timeliness and accuracy of disease surveillance reporting needed to identify and mitigate infectious disease outbreaks and comply with international norms. Further efforts to promote scientific transparency within international collaboration will improve trust, reduce threats, and promote global health security.

Indexed as

biosecurityglobal health securityscientific engagementsequencingthreat reduction

Identifiers

PMID31091687
PMCPMC6631123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.